AllianceBernstein
HCAT icon

AllianceBernstein’s Health Catalyst HCAT Stock Holding History

AllianceBernstein’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-83,770
Closed -$200K – 3369
2026
Q1 		$200K Hold
83,770
– – ﹤0.01% 3053
2025
Q4 		$200K Buy
83,770
+15,000
+22% +$41K ﹤0.01% 3071
2025
Q3 		$196K Hold
68,770
– – ﹤0.01% 3079
2025
Q2 		$259K Buy
68,770
+6,100
+10% +$24K ﹤0.01% 2983
2025
Q1 		$284K Hold
62,670
– – ﹤0.01% 2798
2024
Q4 		$443K Hold
62,670
– – ﹤0.01% 2691
2024
Q3 		$510K Hold
62,670
– – ﹤0.01% 2655
2024
Q2 		$400K Buy
62,670
+14,750
+31% +$94.7K ﹤0.01% 2787
2024
Q1 		$361K Sell
47,920
-5,300
-10% -$48.4K ﹤0.01% 2731
2023
Q4 		$493K Sell
53,220
-121,404
-70% -$992K ﹤0.01% 2616
2023
Q3 		$1.77M Buy
174,624
+40,470
+30% +$483K ﹤0.01% 1952
2023
Q2 		$1.68M Hold
134,154
– – ﹤0.01% 2001
2023
Q1 		$1.57M Hold
134,154
– – ﹤0.01% 2009
2022
Q4 		$1.43M Hold
134,154
– – ﹤0.01% 2102
2022
Q3 		$1.3M Sell
134,154
-4,329,454
-97% -$57.3M ﹤0.01% 2149
2022
Q2 		$64.7M Buy
4,463,608
+627,833
+16% +$10.7M 0.03% 491
2022
Q1 		$100M Buy
3,835,775
+710,896
+23% +$20.2M 0.04% 405
2021
Q4 		$124M Buy
3,124,879
+936,784
+43% +$42.7M 0.04% 376
2021
Q3 		$109M Buy
2,188,095
+63,220
+3% +$3.45M 0.04% 396
2021
Q2 		$118M Buy
2,124,875
+147,927
+7% +$7.88M 0.05% 374
2021
Q1 		$92.5M Buy
1,976,948
+246,103
+14% +$11.9M 0.04% 422
2020
Q4 		$75.3M Buy
1,730,845
+118,890
+7% +$4.39M 0.04% 458
2020
Q3 		$59M Buy
1,611,955
+218,144
+16% +$7.41M 0.03% 495
2020
Q2 		$40.7M Buy
1,393,811
+232,870
+20% +$6.44M 0.02% 568
2020
Q1 		$30.4M Buy
1,160,941
+431,183
+59% +$13.2M 0.02% 572
2019
Q4 		$25.3M Buy
729,758
+296,314
+68% +$9.81M 0.01% 744
2019
Q3 		$13.7M Buy
+433,444
New +$17.1M 0.01% 915

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein's HCAT Position: Q2 2026 in Review

AllianceBernstein sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 83,770 shares — an estimated $200K sold.

AllianceBernstein first reported a position in HCAT in Q3 2019 and held it in 27 quarters. The position peaked at $124M in Q4 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • AllianceBernstein reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • AllianceBernstein sold 83,770 Health Catalyst shares in Q2 2026, an estimated $200K.
  • AllianceBernstein first reported a position in Health Catalyst in Q3 2019 and held it in 27 quarters.
  • AllianceBernstein's Health Catalyst position peaked at $124M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.